Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice

Life Sciences

Volumn 81, Issue 11, 2007, Pages 933-938

  Peng, Wen Huang ^a   Lo, Kuan Lin ^a   Lee, Yi Hsuen ^a   Hung, Tai Huang ^a   Lin, Ying Chih ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antidepressant; Berberine; Forced swim test; Monoamines; Tail suspension test

Indexed keywords

BERBERINE; DESIPRAMINE; DOPAMINE; FLUOXETINE; MAPROTILINE; MOCLOBEMIDE; NORADRENALIN; SEROTONIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINE BLOOD LEVEL; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OPEN FIELD BEHAVIOR; SEROTONIN BLOOD LEVEL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT REFUSAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BERBERINE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HINDLIMB SUSPENSION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; MOVEMENT; PLANT EXTRACTS;

MUS;

EID: 34548526049     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.08.003     Document Type: Article

References (28)

1. Bourin M., Fiocco A.J., and Clenet F. How valuable are animal models in defining antidepressant activity?. Human Psychopharmacology 16 (2001) 9-21
2. Bryant S.G., and Brown C.S. Current concepts in clinical therapeutics: major affective disorders: Part 2. Clinical Pharmacy 5 (1986) 385-395
3. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23 (2002) 238-245
4. D'Aquila P.S., Peana A.T., Carboni V., and Serra G. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress. Journal of Psychopharmacology 14 (2000) 347-352
5. Detke M.J., Rickels M., and Lucki I. Active behavior in the rat forced swim test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
6. Fletcher P.J., Sinyard J., Salsali M., and Baker G.B. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology 174 (2004) 406-413
7. Ivanovska N., and Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. International Journal of Immunopharmacology 18 (1996) 553-561
8. Kanazawa I. Short review on monoamine oxidase and its inhibitors. European Neurology 34 Suppl. 3 (1994) 36-39
9. Kong L.D., Cheng H.K., and Tan R.X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Medica 67 (2001) 74-76
10. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., and Jiang J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Natural Medicine 10 (2004) 1344-1351
11. Lerer B., and Macciardi F. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. International Journal of Neuropsychopharmacology 5 (2002) 255-275
12. Nemeroff C.B., and Owens M.J. Treatment of mood disorders. Nature Neurosciences 5 Suppl l (2002) 1068-1070
13. Park H., Kim M.S., Jeon B.H., Kim T.K., Kim Y.M., Ahnn J., Kwon D.Y., Takaya Y., Wataya Y., and Kim H.S. Antimalarial activity of herbal extracts used in traditional medicine in Korea. Biological & Pharmaceutical Bulletin 26 (2003) 1623-1624
14. Peng W.H., Hsieh M.T., and Wu C.R. Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Japanese Journal of Pharmacology 74 (1997) 261-266
15. Peng W.H., Wu C.R., Chen C.S., Chen C.F., Leu Z.C., and Hsieh M.T. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sciences 75 (2004) 2451-2462
16. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229 (1977) 327-336
17. Porsolt R.D., Anton G., Deniel M., and Jalfre M. Behavioral despair in rats: a new animal model sensitive to antidepressant treatments. European Journal of Pharmacology 47 (1978) 379-391
18. Porsolt R.D., Bertin A., Blavet N., Deniel M., and Jalfre M. Immobility induced by forced swimming in rats: effects of agents, which modify central catecholamine and serotonin activity. European Journal of Pharmacology 57 (1979) 201-210
19. Rabbani G.H., Butler T., Knight J., Sanyal S.C., and Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. Journal of Infective Disease 155 (1987) 979-984
20. Renard C.E., Dailly E., David D.J., Hascot M., and Bourin M. Neurochemical changes following the mouse forced swimming test but not the tail suspension test. Fundamental & Clinical Pharmacology 17 (2003) 449-455
21. Rodrigues A.L., Rocha J.B., Mello C.F., and Souza D.O. Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks. Pharmacology & Toxicology. 79 (1996) 150-156
22. Schmeller T., Latz-Bruning B., and Wink M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44 (1997) 257-266
23. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
24. Willner P. Animal models as simulations of depression. Trends in Pharmacological Science 12 (1991) 131-136
25. Willner P. The validity of animal models of depression. Psychopharmacology 83 (1984) 1-16
26. Wong M.L., and Licinio J. Research and treatment approaches to depression. Nature Reviews Neuroscience 2 (2001) 343-351
27. Zomkowski A.D.E., Rosa A.O., Lin J., Santos A.R.S., Calixto J.B., and Rodrigues A.L.S. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant-like effect in the mouse forced swimming test. Brain Research 1023 (2004) 253-263
28. Zomkowski A.D.E., Santos A.R.S., and Rodrigues A.L.S. Involvement of opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neuroscience Letters 381 (2005) 279-283